SUMMARY
Filippo Pinto e Vairo, M.D., Ph.D., is a clinical geneticist and physician-scientist. Dr. Pinto e Vairo's research focuses on discovering rare and actionable genetic causes of common diseases through population genomics, multi-omics and precision medicine. He integrates genomic data, functional genomics, deep clinical phenotyping and large-scale population studies to improve variant interpretation, uncover new disease mechanisms, and identify new opportunities for diagnosis, prevention and targeted therapy.
By bridging rare disease genetics and population health, Dr. Pinto e Vairo develops scalable genomic medicine programs that translate discovery into clinical care across multiple specialties within the Department of Medicine and beyond.
Focus areas
-
Population genomics and precision health. Dr. Pinto e Vairo develops and applies population-scale genomic approaches to identify individuals with medically actionable genetic conditions before they are recognized through routine clinical care. His goal is to move precision medicine upstream by finding patients at increased genetic risk of disease.
Dr. Pinto e Vairo also creates pathways that enable earlier diagnosis, intervention and prevention. These efforts leverage large genomic datasets, electronic health records and multi-omic technologies to improve healthcare delivery at scale.
-
Rare genetic causes of common diseases. Many common clinical conditions — including liver, gastrointestinal, kidney and pulmonary diseases and other conditions — have rare genetic contributors that remain underrecognized in clinical practice. Dr. Pinto e Vairo identifies these hidden genetic causes through genomic screening, multi-omic analyses, advanced computational methods and translational studies.
Through his research, Dr. Pinto e Vairo redefines disease classification, improves diagnostic precision and identifies patients who may benefit from targeted therapies and disease-specific management strategies.
-
Variant interpretation and functional genomics. A central focus of Dr. Pinto e Vairo's work is understanding why genomic variation causes disease in some individuals but not others. He develops innovative approaches to determine the clinical significance of genomic variants by integrating population-scale genomic resources, functional genomics, transcriptomics, biomarker discovery and detailed clinical phenotyping.
Through his research, Dr. Pinto e Vairo seeks to move beyond traditional variant classification frameworks and establish biologically informed approaches to genomic diagnosis. This approach enables more-precise identification of disease-causing variants and new disease mechanisms.
- Multi-omics and translational genomics. Dr. Pinto e Vairo leads efforts to integrate genomic, transcriptomic, proteomic, metabolomic and phenotypic data to improve disease diagnosis and uncover new biological insights. He develops scalable frameworks that combine diverse sources of molecular and clinical data to increase diagnostic yield and identify therapeutic targets. Dr. Pinto e Vairo also helps accelerate the translation of scientific discoveries into clinical applications.
-
Rare and undiagnosed diseases. As medical director of the Program for Rare and Undiagnosed Diseases, Dr. Pinto e Vairo leads multidisciplinary efforts to shorten the diagnostic journey for patients with rare and undiagnosed conditions.
Through comprehensive genomic and multi-omic investigations, laboratory-based functional studies and global collaborations, Dr. Pinto e Vairo's team works to address unanswered questions and create new opportunities for diagnosis, treatment and disease prevention.
-
Lysosomal and inherited metabolic disorders. Dr. Pinto e Vairo maintains an active interest in lysosomal diseases and inherited metabolic disorders, including Gaucher disease, Pompe disease, Fabry disease and other related conditions. His research has contributed to biomarker discovery, variant interpretation, disease characterization, treatment evaluation and the clinical application of emerging therapies. He continues to inform broader efforts in precision medicine and translational genomics.
Significance to patient care
Dr. Pinto e Vairo improves patient care by identifying disease risk before symptoms develop. Rather than using DNA testing after a person becomes sick, he uses genetic information earlier to identify people at risk and guide their care. By studying DNA and other health information from large groups of people, Dr. Pinto e Vairo works to find individuals at risk of rare but treatable diseases before they develop serious health issues. This helps patients receive the right treatment at the right time.
Dr. Pinto e Vairo works with healthcare teams to bring DNA discoveries into everyday patient care. His research helps healthcare professionals diagnose disease, choose the best treatments, monitor health, prevent harm and connect patients with clinical trials. Together, these efforts support more-personalized care across many areas of medicine.